Philip practices Oncology. Doctor Philip A. Dy, MD is a published doctor. He published 2 publications, including: 'Phase II Study Of The Oral MEK Inhibitor Selumetinib In Advanced Acute Myeloid Leukemia (AML): A University Of Chicago Phase II Consortium Trial.' Philip A. Dy accepts all Medicare patients.
NPI NUMBER | 1710076567 | |
NPPES Provider LastName | DY | |
NPPES Provider FirstName | PHILIP | |
NPPES Provider ZIPCode | 62401 | |
NPPES Provider State | IL | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 2628.0 | |
Distinct Opioid Count | 6.0 | |
Opioid Claim Count | 388.0 | |
Percent Opioid Claims | 14.76 |
National Provider Identifier [NPI] | 1710076567 |
Last Name Of The Provider | DY |
First Name Of The Provider | PHILIP |
View All |
Dr. Hong Chen, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Hanna M. Saba, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. James L. Wade III, MD | |
Dr. Shabbir H. Safdar, MD
This Doctor is OpenDoctor Recommended. |